Price of the veterinary APIs market

The overall price of the veterinary APIs market remained stable and weak, with mixed rising and falling prices and the prices of a few products hitting new lows. The market adjustment is still ongoing. In early April, the prices of florfenicol and tylosin tartrate continued to decline, the market price of doxycycline hydrochloride showed a trend of rising first and then falling, and the average prices of albendazole and levamisole hydrochloride continued to rise MoM. In late April, except for doxycycline hydrochloride, prices fluctuated slightly; most of the mainstream categories of prices were supported by the cost, but the price decline was relatively limited.

The market lacks overall positive news and obvious guiding factors, and it is expected that the market may remain in range-bound consolidation in the short term. However, it is not ruled out that the market supply may be adjusted by shrinking production, such as maintenance and production reduction. In the second quarter, with the recovery of the breeding industry, the downstream demand will improve, and the sluggish situation of the market may be alleviated.

The price followed the previous trend and continued to decline, with an average market price of CNY185/kg hitting a record low since 2018. Weak market demand, continued competition with ample supply, a bearish market mentality, and a cautious attitude at the trade level and the end market have all contributed to the continued decline in florfenicol prices.

The market price index fluctuated and remained stable, bargaining transactions. Market news reported that the upstream supply was gradually relaxed, and trade channels supported the shipment mentality.

Recently, the repeated fluctuation of the doxycycline hydrochloride market price is particularly prominent in the overall weak veterinary APIs market. On the 17th, the average market price of doxycycline was CNY319/kg, up 0.63% from the previous month. The MoM increase of doxycycline recorded a positive value for the first time since 2024, showing a rebound trend in the market price. This rebound is mainly related to factors such as export order fulfilment and rumours of tightening domestic supply. The mainstream manufacturers are suspending quotations and are expected to resume quotations after May Day. Whether the rebound of doxycycline in the future market can be sustained and the strength of the rebound will depend on the changes in supply.

The price of tylosin tartrate still continued the previous sluggish trend, continued to fall and hit a new record low. Some manufacturers chose to limit, suspend or discontinue production, and some took the initiative to sell at reduced prices in order to maintain market share. Pay close attention to the impact of supply-side adjustments on the market.

The vitamin market as a whole remained stable, with a solid wait-and-see and sluggish terminal demand, and with the consumers mainly purchasing as they are using. Vitamin A, Vitamin E and niacinamide continue to suspend reporting and signing, Vitamin B1 and Vitamin B12 market quotations are relatively strong, NHU vitamin C factory plans to stop production for maintenance from May to October, and some Vitamin K3 manufacturers suspend reporting. The demand side is staying rational for wait-and-see and could build a low-volume position at a low level. However, downstream demand is difficult to see a significant improvement in, and the increment is difficult to stimulate; although the inquiry is active, the transaction is average. The vitamin market is expected to have limited changes in the later period and continue to fluctuate.

On April 26, Boyar released a comprehensive report on the performance of listed vitamin companies in 2023. We will post a summarized overview on our company's LinkedIn page. Thank you for your attention and following.

The market quotation is strong, the transaction in domestic and foreign markets is fair, and some factories are in suspension.

BASF's Ludwigshafen plant has been shut down for two months since the end of March.

On April 1st, Kingdomway announced that the company's vitamin factory gradually resumed working and production.

Mainstream foreign manufacturers significantly increased the price last month, and domestic manufacturers and trade channels cater for this by limiting signing, resulting in a worldwide increase in prices in the global market. The recent market prices tend to flatten out, and domestic manufacturers stopped quoting and signing.

BASF's German plant has been shut down for maintenance for two months since the end of March.

On April 11th, the market said that some Vitamin E manufacturers had suspended reporting globally.

Although the mainstream manufacturers released stopping-quotation willingness, the market's wait-and-see mood still remained strong, inventory supplies were gradually reduced, and the market price index oscillation stabilized.

Positive news, such as limited domestic spot supply and production cost enhancement, was released, causing market inquiry to increase, the market price index to oscillate, and market attention to become high.

The amino acid market continued to operate smoothly, and prices of most categories remained stable. Tryptophan has a slightly weaker adjustment; methionine prices are running high. For lysine, threonine, and other products, the market prices are still firm. Order have been placed for delivery later than July, and the current focus is mainly on delivery. The terminal replenishment mood is weak, the market buying and selling atmosphere is relatively light, and close attention must be paid to the recent changes in market demand and transaction status.

On April 25, Boyar released an overview of the performance of listed amino acid companies in 2023. Except for Star Lake Bioscience (production of valine and arginine) and Anhui Huaheng Biotechnology (production of non-essential amino acids), the operating income and net profit of each amino acid manufacturer in the list decreased year-on-year, especially the net profit, which decreased by 20%- 90%, mainly due to the price decline in 2023.

METabolic EXplorer (METEX) recently announced that its amino acid plant in Amiens, France (which produces lysine, tryptophan and valine) will be shut down for two weeks in the second half of April.

The market reported that Jinyufeng's lysine production capacity would be released; Ningxia CUC Met (methionine producer) is scheduled to be shut down for maintenance for 4-5 weeks in Q2; Tongliao Meihua plans to change the tryptophan production workshop for isoleucine, with a design capacity of 6500MT/a Evonik's methionine plant in Singapore will be shut down for maintenance in the Q2.

Curcumin is a polyphenol extracted from turmeric. It has the potential to mitigate heat stress (HS) in poultry through various mechanisms, such as reducing oxidative stress and inflammation.

Various research and studies have proven that

---Feed with curcumin improves the growth performance of heat-stressed broiler birds;

---Feed with curcumin improved the laying performance, egg quality,antioxidant enzyme activity and immune function during HS.

It’s supplied in 95% assay and 10% premix and is recommended for consumption in poultry, pigs, dairy, and aquatic animals.

(Feed grade Potassium Diformate)

Magiacid KDF is the trade name of feed-grade Potassium Diformate.

Potassium Diformate is a specifically conjugated acid double-salt which has been approved in the EU as a non-antibiotic growth promoter to support the growth of beneficial microflora and improve gastrointestinal balance. Experiments and field applications have proven that the product is safe, highly efficient, non-toxic and residual-free for use in farming animals.